Company intelligence / Profile preview

CCB International

Ownership: Private
Development stage: Other

Overview

CCB International is the flagship investment banking and asset management subsidiary of China Construction Bank, providing services such as corporate finance, capital markets, direct investment, and asset management. It operates several industry-focused private equity funds—including one of the first Chinese healthcare industry funds—investing in pharmaceutical, medical device, and health service companies. However, it does not itself develop drugs or own clinical programs.

Industry: Investors

Beyond the preview

Go deeper on CCB International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCB International.

Explore the full profile